Parenteral agent dispensing equipment

Claim 2

A formulation chamber for use in a parenteral delivery system, comprising: (a) a wall surrounding an internal lumen; (b) an inlet for admitting a fluid into the chamber; (c) an outlet for letting a fluid leave the chamber; and, (d) an erodible delivery system in the chamber, comprising: (1) a matrix formed of a parenterally-acceptable material that erodes in the presence of a parenteral fluid over time, and; (2) a beneficial agent dispersed in the matrix that is delivered by the erodible delivery system into parenteral fluid that enters the formulation chamber.

Claim 3

The formulation chamber for use in a parenteral delivery system according to claim 1, wherein the chamber contains a separate film that aids in controlling the rate of release of agent formulation from the chamber.

Claim 4

The formulation chamber for use in a parenteral delivery system according to claim 1, wherein the chamber contains a separate porous film that aids in controlling the rate of release of agent formulation from the chamber.

Claim 5

The formulation chamber for use in a parenteral delivery system according to claim 1, wherein the chamber contains a perforated grid that supports erodible delivery system in the chamber.

Claim 6

The formulation chamber for use in a parenteral delivery system according to claim 1, wherein the parenteral delivery system comprises a drip chamber in fluid communication with the formulation chamber.

Claim 7

An intravenous delivery system for administering a beneficial agent intravenously to a human, comprising: (a) a container of a pharmaceutically acceptable liquid; (b) a drip chamber in fluid communication with the container for determining the rate of fluid flow through the intravenous system for the continuous drip administration of liquid; and, (c) a formulation comprising: (1) a wall surrounding a lumen; (2) an erodible agent delivery system in the chamber comprising a matrix formed of a polymer containing agent dispersed therein, which matrix erodes in the presence of a pharmaceutically acceptable liquid that enters the formulation chamber; and, (3) wherein the formulation chamber is in fluid communication with the drip chamber such that liquid flows into the formulation chamber and forms with agent released from the matrix an agent formulation over time.

Claim 8

An intravenous delivery system for administering a beneficial agent intravenously to a human, comprising: (a) a container of a pharmaceutically acceptable liquid; (b) a drip chamber in fluid communication with the container for determining the rate of fluid flow through the intravenous system for the continuous drip administration of liquid; and, (c) a formulation comprising: (1) a wall surrounding a lumen; (2) an erodible agent delivery system in the chamber comprising a matrix formed of a polymer containing agent dispersed therein, which matrix erodes in the presence of a pharmaceutically acceptable liquid that enters the formulation chamber; and, (3) wherein the formulation chamber is in fluid communication with the drip chamber such that liquid flows into the formulation chamber and forms with agent released from the matrix an agent formulation over time.